Lobbying

Lash Opco's latest lobbying report covers Q2 2026, at $140K. Its first report covers Q1 2026; the issues it reports most are Health Issues.

Lash Opco

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$230K
Last 3 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2026
The first quarter a report named it

Lobbying by quarter

Lash Opco lobbying by quarter
Lash Opco lobbying by quarter
QuarterAmountReports
Q1 2026$90K1
Q2 2026$140K1
Q3 2026$00

By issue

  • Health issues$230K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES2 reports
  • SENATE2 reports
  • Food & Drug Administration (FDA)1 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • White House Office1 reports

Firms it paid

Firm
Foley & Lardner$230K2 quarters

Former officials lobbying for it

Former position
JENNIFER FITZGERALD WALSHAA; Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic CaucusQ2 2026
JOHN STROMSenior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural ResourcesQ2 2026
KATIE SCHOETTLERCommunications Director & Senior Advisor - U.S. Senator Steve Daines; Press Secretary - House Committee on Natural ResourcesQ2 2026

Lobbying reports

Filed by
07/19for Q2Foley & Lardner$140K
04/20for Q1Foley & Lardner$90K
04/20for Q1Foley & LardnerUnder $5,000